Many transgenic mouse models have been developed to target cells expressing high levels of p16Ink4a (p16high) and investigate their potential contribution to tissue dysfunction in aging, obesity, and other pathological conditions. This evidence concerns the gene CDKN2A and obesity due to melanocortin 4 receptor deficiency.